Elizabeth Eisenhauer

Elizabeth Eisenhauer is a Canadian oncologist who has spent a large portion of her career undertaking phase I and II trials of novel cancer therapies through her role as Director of the Investigational New Drug Program in the Canadian Cancer Trials Group. She received her Doctor of Medicine degree from Queen's University

In 2012, she was awarded with the Queen Elizabeth II Diamond Jubilee medal for “her tremendous commitment to the advancement of cancer therapy, supportive care and prevention across Canada and internationally.” and in 2017, she was inducted as an Officer of the Order of Canada.